id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2017-P-7032-0006,FDA,FDA-2017-P-7032,Petition Approval Letter from FDA CDER to Jubilant Generics Limited,Other,Agency Response,2021-08-12T04:00:00Z,2021,8,2021-08-12T04:00:00Z,,2021-08-12T15:30:52Z,,0,0,0900006484c4a80a